Human Genome Sciences Q1 Revenue Shrivels as R&D Costs Surge

Apr 15, 2002

NEW YORK, April 15 - Human Genome Sciences said today that poor income from collaborations caused first-quarter revenue to plummet to $600,000 from $5.3 million during the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Cancer Dependency Maps Developed by Two Research Teams
Error-Prone DNA Repair Implicated in Analysis of Cancer Mutation Signature Clusters
Ancient Genome Sequences Point to Canaanite Ancestry in Present-Day Lebanese Population
Qiagen Q2 Revenues Grow 4 Percent; Firm Nudges Up Full-Year Guidance
Biomatrica Gets CE-IVD Marks for Sample Collection Tubes
Meridian Bio Q3 Revenues Inch Down 1 Percent

The Scan

Embryos Edited in US

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

True Blue

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

All the Plants

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

This Week in Nature

In Nature this week: a Danish reference genome, and more.

Main menu